Abstract
To evaluate the accuracy of scout dose resin-based yttrium-90 (Y-90) microspheres vs. technetium-99m (Tc99m) macroaggregated albumin (MAA) for personalized treatment planning in patients with hepatocellular carcinoma (HCC)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
